Literature DB >> 9121556

The Pax4 gene is essential for differentiation of insulin-producing beta cells in the mammalian pancreas.

B Sosa-Pineda1, K Chowdhury, M Torres, G Oliver, P Gruss.   

Abstract

The mammalian pancreas contains two distinct cell populations: endocrine cells which secrete hormones into the bloodstream, and exocrine cells, which secrete enzymes into the digestive tract. The four endocrine cell types found in the adult pancreas-(alpha, beta, delta and PP-synthesize glucagon, insulin, somatostatin and pancreatic polypeptide, respectively. All of these endocrine cells arise from common multipotent precursors, which coexpress several hormones when they start to differentiate. Expression of some homeobox genes in the early developing pancreas has been reported. The Pax4 gene is expressed in the early pancreas, but is later restricted to beta cells. Inactivation of Pax4 by homologous recombination results in the absence of mature insulin- and somatostatin-producing cells (beta and delta, respectively) in the pancreas of Pax4 homozygous mutant mice, but glucagon-producing alpha cells are present in considerably higher numbers. We propose that the early expression of Pax4 in a subset of endocrine progenitors is essential for the differentiation of the beta and delta cell lineages. A default pathway would explain the elevated number of alpha cells in the absence of Pax4.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9121556     DOI: 10.1038/386399a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  246 in total

Review 1.  Neurosecretory cells without neurosecretion: evidence of an independently regulated trait of the cell phenotype.

Authors:  M L Malosio; R Benfante; G Racchetti; B Borgonovo; P Rosa; J Meldolesi
Journal:  J Physiol       Date:  1999-10-01       Impact factor: 5.182

2.  [Clinical research in Germany].

Authors:  H D Söling
Journal:  Med Klin (Munich)       Date:  1999-05-15

Review 3.  Developmental aspects of the endocrine pancreas.

Authors:  Daniel M Kemp; Melissa K Thomas; Joel F Habener
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

4.  Nephric lineage specification by Pax2 and Pax8.

Authors:  Maxime Bouchard; Abdallah Souabni; Markus Mandler; Annette Neubüser; Meinrad Busslinger
Journal:  Genes Dev       Date:  2002-11-15       Impact factor: 11.361

Review 5.  Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.

Authors:  Dan P Christensen; Mattias Dahllöf; Morten Lundh; Daniel N Rasmussen; Mette D Nielsen; Nils Billestrup; Lars G Grunnet; Thomas Mandrup-Poulsen
Journal:  Mol Med       Date:  2011-01-25       Impact factor: 6.354

6.  Ectopic expression of the beta-cell specific transcription factor Pdx1 inhibits glucagon gene transcription.

Authors:  B Ritz-Laser; B R Gauthier; A Estreicher; A Mamin; T Brun; F Ris; P Salmon; P A Halban; D Trono; J Philippe
Journal:  Diabetologia       Date:  2003-06-03       Impact factor: 10.122

7.  Neurogenin3 triggers beta-cell differentiation of retinoic acid-derived endoderm cells.

Authors:  Amedeo Vetere; Eleonora Marsich; Matteo Di Piazza; Raffaella Koncan; Fulvio Micali; Sergio Paoletti
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

8.  The PAX6 gene is activated by the basic helix-loop-helix transcription factor NeuroD/BETA2.

Authors:  Eleonora Marsich; Amedeo Vetere; Matteo Di Piazza; Gianluca Tell; Sergio Paoletti
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

9.  Lineage Plasticity in Cancer Progression and Treatment.

Authors:  Clémentine Le Magnen; Michael M Shen; Cory Abate-Shen
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01

10.  An endocrine-exocrine switch in the activity of the pancreatic homeodomain protein PDX1 through formation of a trimeric complex with PBX1b and MRG1 (MEIS2).

Authors:  G H Swift; Y Liu; S D Rose; L J Bischof; S Steelman; A M Buchberg; C V Wright; R J MacDonald
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.